Back to results
US 12,252,459 B2Granted
Hydrazone amide derivatives and use thereof in preparation of anti-osteoporosis drugs
AssigneeShenzhen Cell Inspire Pharmaceutical Development Co., Ltd.
InventorsDane Huang, Chao Zhao, Qiong Gu, Jun Xu
Life of this patent
Estimating the term…
Abstract
Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new class of compounds with an anti-osteoporosis effect.
Claims2
A method for treating or preventing osteoporosis or osteopenia, the method comprising:
- administering a compound having one of the following structures or a stereoisomer, geometric isomer, tautomer, nitrogen oxide, hydrate, or solvate thereof, or a pharmaceutically acceptable salt or prodrug of the compound having one of the following structures to a patient:
A method for treating or preventing osteoporosis or osteopenia, the method comprising:
- administering a pharmaceutical composition to a patient, wherein the pharmaceutical composition comprises a compound having one of the following structures or a stereoisomer, geometric isomer, tautomer, nitrogen oxide, hydrate, or solvate thereof, or a pharmaceutically acceptable salt or prodrug of the compound having one of the following structures:
Dependencies are inferred from the claim text.